| NCT03343730 |
RetinaVue Diabetic Screening |
https://ClinicalTrials.gov/show/NCT03343730 |
Recruiting |
Bassett Healthcare |
2018-10-01 |
| NCT03278587 |
Village-Integrated Eye Worker Trial II - Pilot |
https://ClinicalTrials.gov/show/NCT03278587 |
Recruiting |
Francis I. Proctor Foundation |
2020-08-31 |
| NCT03242031 |
Medico-economic Comparison Between Treatment With Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03242031 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2021-03-31 |
| NCT03238963 |
A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. |
https://ClinicalTrials.gov/show/NCT03238963 |
Completed |
Boehringer Ingelheim |
2020-02-14 |
| NCT03197870 |
The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) |
https://ClinicalTrials.gov/show/NCT03197870 |
Completed |
Aerpio Therapeutics |
2019-01-09 |
| NCT03161652 |
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03161652 |
Recruiting |
Universidad Nacional Autonoma de Mexico |
2022-05-31 |
| NCT03150654 |
The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes |
https://ClinicalTrials.gov/show/NCT03150654 |
Completed |
Afyon Kocatepe University Hospital |
2016-06-08 |
| NCT03113006 |
The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT) |
https://ClinicalTrials.gov/show/NCT03113006 |
Completed |
Odense University Hospital |
2019-08-27 |
| NCT03094819 |
PROTECT2: Diabetes Care - Eye Exam |
https://ClinicalTrials.gov/show/NCT03094819 |
Active, not recruiting |
Retinal Care Inc. |
2021-06-30 |
| NCT03071068 |
A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) |
https://ClinicalTrials.gov/show/NCT03071068 |
Completed |
ThromboGenics |
2018-04-30 |
| NCT02995629 |
Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation |
https://ClinicalTrials.gov/show/NCT02995629 |
Completed |
Wills Eye |
2016-10-31 |
| NCT02911311 |
Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02911311 |
Enrolling by invitation |
Sun Yat-sen University |
2019-12-31 |
| NCT02879422 |
Genetic Markers and Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02879422 |
Recruiting |
CHU de Reims |
2020-04-16 |
| NCT02874313 |
CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea |
https://ClinicalTrials.gov/show/NCT02874313 |
Active, not recruiting |
Hospital Universitario La Paz |
2020-10-31 |
| NCT02866734 |
Diabetic Retinopathy Screening in Private Practice |
https://ClinicalTrials.gov/show/NCT02866734 |
Completed |
The University of Hong Kong |
2017-12-13 |
| NCT02863354 |
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02863354 |
Active, not recruiting |
Greater Houston Retina Research |
2019-07-31 |
| NCT02858076 |
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR |
https://ClinicalTrials.gov/show/NCT02858076 |
Completed |
Jaeb Center for Health Research |
2020-01-31 |
| NCT02857491 |
Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02857491 |
Completed |
Sun Yat-sen University |
2017-09-30 |
| NCT02834663 |
Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02834663 |
Completed |
Wonkwang University Hospital |
2019-02-28 |
| NCT02826655 |
Adaptive Optics for Ophthalmic Technologies |
https://ClinicalTrials.gov/show/NCT02826655 |
Recruiting |
Duke University |
2021-06-30 |
| NCT02823600 |
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers |
https://ClinicalTrials.gov/show/NCT02823600 |
Completed |
University of North Carolina, Chapel Hill |
2017-05-31 |
| NCT02816710 |
Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02816710 |
Completed |
Ruijin Hospital |
2017-09-30 |
| NCT02816073 |
Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02816073 |
Completed |
United Christian Hospital |
2013-11-30 |
| NCT02806830 |
Ocular Discomfort Assessment After Intravitreal Injections |
https://ClinicalTrials.gov/show/NCT02806830 |
Completed |
Centre Hospitalier Intercommunal Creteil |
2017-01-31 |
| NCT02753400 |
Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02753400 |
Completed |
Kubota Vision Inc. |
2017-11-30 |
| NCT02718326 |
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) |
https://ClinicalTrials.gov/show/NCT02718326 |
Completed |
Regeneron Pharmaceuticals |
2018-08-06 |
| NCT02706977 |
The Effect of Dopamine on Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02706977 |
Completed |
Emory University |
2019-08-15 |
| NCT04424290 |
HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia |
https://ClinicalTrials.gov/show/NCT04424290 |
Recruiting |
Boehringer Ingelheim |
2022-05-18 |
| NCT02705274 |
PRP vs Bevacizumab for PDR Treatment |
https://ClinicalTrials.gov/show/NCT02705274 |
Completed |
Marashi Eye Clinic |
2017-04-30 |
| NCT02691429 |
Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans |
https://ClinicalTrials.gov/show/NCT02691429 |
Completed |
Federal University of São Paulo |
2016-11-30 |
| NCT02681809 |
A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR |
https://ClinicalTrials.gov/show/NCT02681809 |
Completed |
Oxurion |
2019-11-18 |
| NCT02647515 |
Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma |
https://ClinicalTrials.gov/show/NCT02647515 |
Completed |
Ruijin Hospital |
2014-12-31 |
| NCT02645383 |
PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System |
https://ClinicalTrials.gov/show/NCT02645383 |
Completed |
Kocatepe University |
2014-07-31 |
| NCT02634333 |
Anti-VEGF Treatment for Prevention of PDR/DME |
https://ClinicalTrials.gov/show/NCT02634333 |
Active, not recruiting |
Jaeb Center for Health Research |
2020-05-31 |
| NCT02621580 |
Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT02621580 |
Completed |
Lawson Health Research Institute |
2017-08-31 |
| NCT02590094 |
Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy |
https://ClinicalTrials.gov/show/NCT02590094 |
Recruiting |
Panhandle Eye Group, LLP |
2021-10-31 |
| NCT02587741 |
Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens |
https://ClinicalTrials.gov/show/NCT02587741 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2023-07-31 |
| NCT04120077 |
Combined Effects of Diabetes Self-Management Education and Nutritional Supplementation on Visual Function and Retinopathy |
https://ClinicalTrials.gov/show/NCT04120077 |
Recruiting |
ZeaVision, LLC |
2020-11-01 |
| NCT04117022 |
Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG |
https://ClinicalTrials.gov/show/NCT04117022 |
Recruiting |
ZeaVision, LLC |
2020-12-01 |
| NCT02559180 |
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab |
https://ClinicalTrials.gov/show/NCT02559180 |
Recruiting |
The Cleveland Clinic |
2020-11-30 |
| NCT02521116 |
Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap |
https://ClinicalTrials.gov/show/NCT02521116 |
Completed |
Medical University of Vienna |
2017-01-03 |
| NCT02510885 |
SD-OCT Angiography |
https://ClinicalTrials.gov/show/NCT02510885 |
Recruiting |
Duke University |
2020-05-31 |
| NCT02475109 |
Study of Topical Ocular PAN-90806 in PDR |
https://ClinicalTrials.gov/show/NCT02475109 |
Completed |
PanOptica, Inc. |
2016-05-31 |
| NCT02457975 |
Photobiomodulation for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02457975 |
Completed |
Medical College of Wisconsin |
2019-08-30 |
| NCT02447185 |
25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT02447185 |
Recruiting |
The First People’s Hospital of Xuzhou |
2020-12-31 |
| NCT02435862 |
A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02435862 |
Completed |
Allegro Ophthalmics, LLC |
2017-08-10 |
| NCT02432547 |
Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) |
https://ClinicalTrials.gov/show/NCT02432547 |
Active, not recruiting |
University of Sydney |
2021-01-31 |
| NCT02390245 |
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study |
https://ClinicalTrials.gov/show/NCT02390245 |
Active, not recruiting |
Wills Eye |
2019-09-30 |
| NCT02366468 |
Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema |
https://ClinicalTrials.gov/show/NCT02366468 |
Completed |
Novartis |
2017-06-08 |
| NCT02339909 |
Incentives in Diabetic Eye Assessment by Screening |
https://ClinicalTrials.gov/show/NCT02339909 |
Completed |
Imperial College London |
2015-12-31 |
| NCT02307110 |
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy |
https://ClinicalTrials.gov/show/NCT02307110 |
Completed |
Vista Klinik |
2014-12-31 |
| NCT02261194 |
Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02261194 |
Completed |
Maisonneuve-Rosemont Hospital |
2016-02-29 |
| NCT02249897 |
PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs |
https://ClinicalTrials.gov/show/NCT02249897 |
Completed |
University of Chile |
2017-12-31 |
| NCT02207712 |
Noctura400 Treatment for Diabetic Retinopathy (CANDLE) |
https://ClinicalTrials.gov/show/NCT02207712 |
Active, not recruiting |
PolyPhotonix Medical |
2020-07-31 |
| NCT02177747 |
Smartphone-based Ophthalmoscopy |
https://ClinicalTrials.gov/show/NCT02177747 |
Completed |
Università degli Studi di Brescia |
2014-04-30 |
| NCT02157350 |
The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT |
https://ClinicalTrials.gov/show/NCT02157350 |
Completed |
Odense University Hospital |
2017-09-30 |
| NCT02151695 |
Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy. |
https://ClinicalTrials.gov/show/NCT02151695 |
Completed |
Poitiers University Hospital |
2018-10-31 |
| NCT02121340 |
Collaborative Care for Depression and Diabetic Retinopathy in African Americans |
https://ClinicalTrials.gov/show/NCT02121340 |
Completed |
Thomas Jefferson University |
2018-12-31 |
| NCT02099981 |
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients |
https://ClinicalTrials.gov/show/NCT02099981 |
Completed |
University of Minnesota |
2017-12-31 |
| NCT02085681 |
Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases |
https://ClinicalTrials.gov/show/NCT02085681 |
Completed |
Aravind Eye Care System |
2015-01-31 |
| NCT02062034 |
Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02062034 |
Completed |
University of Guadalajara |
2013-11-30 |
| NCT01298076 |
Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01298076 |
Completed |
University of Sydney |
2014-09-30 |
| NCT01295775 |
Diabetic Retinopathy Sulodexide Study |
https://ClinicalTrials.gov/show/NCT01295775 |
Completed |
Ajou University School of Medicine |
2011-04-30 |
| NCT01281098 |
Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. |
https://ClinicalTrials.gov/show/NCT01281098 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2012-10-31 |
| NCT01280929 |
Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01280929 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2013-12-31 |
| NCT01270542 |
Avastin for PDR (Proliferative Diabetic Retinopathy) |
https://ClinicalTrials.gov/show/NCT01270542 |
Completed |
University of Southern California |
2011-07-31 |
| NCT02040441 |
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria |
https://ClinicalTrials.gov/show/NCT02040441 |
Completed |
Steno Diabetes Center Copenhagen |
2018-11-30 |
| NCT01988246 |
Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01988246 |
Completed |
The Cleveland Clinic |
2018-04-25 |
| NCT01976923 |
Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01976923 |
Completed |
King Khaled Eye Specialist Hospital |
2018-07-31 |
| NCT01950663 |
RETeval Study for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01950663 |
Completed |
Inoveon Corporation |
2014-04-30 |
| NCT01941329 |
Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. |
https://ClinicalTrials.gov/show/NCT01941329 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2016-04-30 |
| NCT01927315 |
Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes |
https://ClinicalTrials.gov/show/NCT01927315 |
Completed |
University of Padova |
2019-10-31 |
| NCT01920984 |
Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01920984 |
Completed |
National Taiwan University Hospital |
2006-12-31 |
| NCT01908816 |
An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. |
https://ClinicalTrials.gov/show/NCT01908816 |
Completed |
Novartis |
2016-01-08 |
| NCT01875783 |
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits |
https://ClinicalTrials.gov/show/NCT01875783 |
Completed |
Joslin Diabetes Center |
2015-05-14 |
| NCT01872611 |
Nepafenac Once Daily for Macular Edema - Study 2 |
https://ClinicalTrials.gov/show/NCT01872611 |
Completed |
Alcon Research |
2015-05-31 |
| NCT01869933 |
Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X |
https://ClinicalTrials.gov/show/NCT01869933 |
Completed |
OcuCure Therapeutics, Inc. |
2013-06-30 |
| NCT01854593 |
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01854593 |
Completed |
Nihon University |
2013-08-31 |
| NCT01837121 |
a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China |
https://ClinicalTrials.gov/show/NCT01837121 |
Completed |
Sun Yat-sen University |
2017-06-30 |
| NCT01813773 |
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study |
https://ClinicalTrials.gov/show/NCT01813773 |
Completed |
Ophthalmic Consultants of Long Island |
2016-04-30 |
| NCT01805297 |
Aflibercept Injection for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01805297 |
Completed |
University of Oklahoma |
2014-02-28 |
| NCT01787669 |
Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01787669 |
Completed |
University of Sydney |
2017-01-31 |
| NCT01769183 |
Squalamine for the Treatment in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01769183 |
Completed |
Elman Retina Group |
2014-08-31 |
| NCT01766362 |
Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients. |
https://ClinicalTrials.gov/show/NCT01766362 |
Completed |
Centre Hospitalier Universitaire Dijon |
2015-11-30 |
| NCT01758757 |
Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01758757 |
Completed |
Kyorin University |
2011-01-31 |
| NCT01746563 |
Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01746563 |
Completed |
University of Sao Paulo |
2012-08-31 |
| NCT01744132 |
Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes |
https://ClinicalTrials.gov/show/NCT01744132 |
Completed |
Wills Eye |
2016-10-31 |
| NCT01743781 |
Uptake of Comprehensive Eye Examination Trial |
https://ClinicalTrials.gov/show/NCT01743781 |
Completed |
Sun Yat-sen University |
2013-09-30 |
| NCT01736059 |
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy |
https://ClinicalTrials.gov/show/NCT01736059 |
Enrolling by invitation |
University of California, Davis |
2022-01-31 |
| NCT01726075 |
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01726075 |
Completed |
BCN Peptides |
2015-11-30 |
| NCT01724554 |
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion |
https://ClinicalTrials.gov/show/NCT01724554 |
Completed |
Ophthalmic Consultants of Boston |
2014-10-31 |
| NCT01724385 |
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01724385 |
Completed |
Khon Kaen University |
2012-12-31 |
| NCT01694212 |
Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01694212 |
Completed |
Eye Clinic Medic Zuljan Jukic |
2016-10-31 |
| NCT01646047 |
Diabetes Visual Function Supplement Study |
https://ClinicalTrials.gov/show/NCT01646047 |
Completed |
ZeaVision, LLC |
2014-08-31 |
| NCT01628289 |
The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong |
https://ClinicalTrials.gov/show/NCT01628289 |
Completed |
The University of Hong Kong |
2009-08-31 |
| NCT01627977 |
Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy |
https://ClinicalTrials.gov/show/NCT01627977 |
Completed |
Federal University of São Paulo |
2014-01-31 |
| NCT01594281 |
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) |
https://ClinicalTrials.gov/show/NCT01594281 |
Completed |
Novartis |
2016-11-30 |
| NCT01571232 |
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01571232 |
Completed |
Retina Macula Institute |
2014-02-28 |
| NCT01535495 |
Propranolol for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01535495 |
Completed |
University of Wisconsin, Madison |
2015-12-31 |
| NCT01506895 |
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01506895 |
Completed |
GlaxoSmithKline |
2013-02-28 |
| NCT01504724 |
Effect of the Adjunctive IVB Before PRP |
https://ClinicalTrials.gov/show/NCT01504724 |
Completed |
Kyungpook National University Hospital |
2012-08-31 |
| NCT01489189 |
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01489189 |
Completed |
Jaeb Center for Health Research |
2015-01-31 |
| NCT01487070 |
A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01487070 |
Completed |
Retina Institute of Hawaii |
2011-07-31 |
| NCT01476449 |
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema |
https://ClinicalTrials.gov/show/NCT01476449 |
Completed |
Retina Vitreous Associates of Florida |
2016-09-30 |
| NCT01445899 |
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01445899 |
Completed |
Quark Pharmaceuticals |
2013-11-30 |
| NCT01383772 |
Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility |
https://ClinicalTrials.gov/show/NCT01383772 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2014-08-31 |
| NCT01373476 |
Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01373476 |
Completed |
Chengdu University of Traditional Chinese Medicine |
2013-03-31 |
| NCT01364129 |
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01364129 |
Completed |
Legacy Health System |
2011-12-31 |
| NCT01323348 |
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control |
https://ClinicalTrials.gov/show/NCT01323348 |
Completed |
Jaeb Center for Health Research |
2014-07-31 |
| NCT01320345 |
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. |
https://ClinicalTrials.gov/show/NCT01320345 |
Recruiting |
University of Sydney |
2022-01-31 |
| NCT01319487 |
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01319487 |
Completed |
Fovea Pharmaceuticals SA |
2012-03-31 |
| NCT04436900 |
Evaluation of Macular Structural and Functional Function Following Extensive Retinal Laser Therapy in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT04436900 |
Completed |
Baqiyatallah Medical Sciences University |
2019-02-10 |
| NCT04418427 |
ADVM-022 Intravitreal Gene Therapy for DME |
https://ClinicalTrials.gov/show/NCT04418427 |
Recruiting |
Adverum Biotechnologies, Inc. |
2021-05-31 |
| NCT04380077 |
Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics |
https://ClinicalTrials.gov/show/NCT04380077 |
Recruiting |
Rush Eye Associates |
2024-06-01 |
| NCT04380064 |
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT04380064 |
Recruiting |
Rush Eye Associates |
2024-06-01 |
| NCT04359771 |
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04359771 |
Completed |
Cairo University |
2018-09-25 |
| NCT04285151 |
Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes |
https://ClinicalTrials.gov/show/NCT04285151 |
Completed |
Tanta University |
2020-01-31 |
| NCT04271709 |
Manhattan Vision Screening and Follow-Up Study |
https://ClinicalTrials.gov/show/NCT04271709 |
Recruiting |
Columbia University |
2024-09-30 |
| NCT04265261 |
A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT04265261 |
Recruiting |
Hoffmann-La Roche |
2022-02-09 |
| NCT04215445 |
Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD |
https://ClinicalTrials.gov/show/NCT04215445 |
Recruiting |
National University of Malaysia |
2020-05-31 |
| NCT04187443 |
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema |
https://ClinicalTrials.gov/show/NCT04187443 |
Recruiting |
MingSight Pharmaceuticals Pty Limited |
2021-08-18 |
| NCT04141891 |
Advancing Understanding of Transportation Options |
https://ClinicalTrials.gov/show/NCT04141891 |
Recruiting |
University of Colorado, Denver |
2023-08-01 |
| NCT04103671 |
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR |
https://ClinicalTrials.gov/show/NCT04103671 |
Recruiting |
Zhongshan Ophthalmic Center, Sun Yat-sen University |
2021-12-31 |
| NCT04071977 |
Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT04071977 |
Recruiting |
University of Guadalajara |
2021-01-31 |
| NCT04038125 |
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME |
https://ClinicalTrials.gov/show/NCT04038125 |
Recruiting |
Retina Macula Specialists of Miami, LLC |
2020-08-31 |
| NCT04018482 |
Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) |
https://ClinicalTrials.gov/show/NCT04018482 |
Completed |
California Retina Consultants |
2019-08-14 |
| NCT03973762 |
A Blinded, Self-control Trial to Evaluate an Artificial Intelligence Based CAD System for Diabetic Retinography |
https://ClinicalTrials.gov/show/NCT03973762 |
Recruiting |
Peking Union Medical College Hospital |
2020-08-15 |
| NCT03970161 |
Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03970161 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2021-06-01 |
| NCT03962296 |
A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon® |
https://ClinicalTrials.gov/show/NCT03962296 |
Completed |
Hanyang University |
2015-01-26 |
| NCT03956797 |
Long Term Safety of Cooling Anesthesia for Intravitreal Injection |
https://ClinicalTrials.gov/show/NCT03956797 |
Recruiting |
Recens Medical, Inc. |
2020-05-30 |
| NCT03904056 |
ETDRS PRP With IVR Versus Retinal Photocoagulation Targeted to Ischemic Retina With IVR for the Treatment of PDR |
https://ClinicalTrials.gov/show/NCT03904056 |
Completed |
São Paulo State University |
2017-07-01 |
| NCT03902925 |
Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia |
https://ClinicalTrials.gov/show/NCT03902925 |
Completed |
University of Sao Paulo |
2019-08-31 |
| NCT03901898 |
Feasibility of an Intervention to Increase Diabetic Retinopathy Screening Attendance |
https://ClinicalTrials.gov/show/NCT03901898 |
Active, not recruiting |
University College Cork |
2020-06-30 |
| NCT03863535 |
PRP vs PRP+IVC for Severe nPDR |
https://ClinicalTrials.gov/show/NCT03863535 |
Recruiting |
Ruijin Hospital |
2021-01-01 |
| NCT03859245 |
Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer’s Disease Prevention |
https://ClinicalTrials.gov/show/NCT03859245 |
Recruiting |
Bristlecone Health, Inc. |
2020-09-30 |
| NCT03828890 |
Assess Screening for Diabetic Retinopathy Using Retinal Camera in Family Medicine Clinic |
https://ClinicalTrials.gov/show/NCT03828890 |
Completed |
Mayo Clinic |
2020-03-15 |
| NCT03765112 |
Macular Involvement in Diabetic Retinopathy Evaluated With Swept-Source OCT |
https://ClinicalTrials.gov/show/NCT03765112 |
Recruiting |
University of British Columbia |
2019-12-31 |
| NCT03755752 |
Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT03755752 |
Completed |
Assiut University |
2018-07-25 |
| NCT03702374 |
Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03702374 |
Recruiting |
University of Guadalajara |
2021-01-31 |
| NCT03696810 |
Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2 |
https://ClinicalTrials.gov/show/NCT03696810 |
Active, not recruiting |
Association for Innovation and Biomedical Research on Light and Image |
2019-12-31 |
| NCT03680794 |
Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies |
https://ClinicalTrials.gov/show/NCT03680794 |
Recruiting |
CHU de Reims |
2021-12-01 |
| NCT03672656 |
Pattern Laser Versus Conventional Laser in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03672656 |
Completed |
University Hospital Ostrava |
2013-12-31 |
| NCT03666923 |
A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT03666923 |
Completed |
Oxurion |
2019-11-20 |
| NCT03660384 |
Silicone Oil Versus Long-acting Gas Tamponade in Proliferative Diabetic Retinopathy Patients With High-grade Vitreoretinal Adhesion Undergoing Vitrectomy |
https://ClinicalTrials.gov/show/NCT03660384 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03660371 |
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging |
https://ClinicalTrials.gov/show/NCT03660371 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03660345 |
Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03660345 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03531294 |
Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement |
https://ClinicalTrials.gov/show/NCT03531294 |
Active, not recruiting |
Greater Houston Retina Research |
2021-04-30 |
| NCT03511898 |
A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT03511898 |
Completed |
Oxurion |
2019-05-22 |
| NCT03499223 |
A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) |
https://ClinicalTrials.gov/show/NCT03499223 |
Completed |
Oxurion |
2019-07-18 |
| NCT03478306 |
Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm |
https://ClinicalTrials.gov/show/NCT03478306 |
Recruiting |
Glostrup University Hospital, Copenhagen |
2020-10-01 |
| NCT03453281 |
Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection |
https://ClinicalTrials.gov/show/NCT03453281 |
Completed |
Indonesia University |
2018-04-09 |
| NCT03439345 |
Lowering Events in Non-proliferative Retinopathy in Scotland |
https://ClinicalTrials.gov/show/NCT03439345 |
Recruiting |
University of Oxford |
2023-08-31 |
| NCT03426540 |
Intravitreal Conbercept After Vitrectomy |
https://ClinicalTrials.gov/show/NCT03426540 |
Completed |
Tianjin Medical University Eye Hospital |
2018-03-30 |
| NCT03422965 |
Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT03422965 |
Recruiting |
Hospital Clinic of Barcelona |
2019-05-08 |
| NCT01257815 |
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment |
https://ClinicalTrials.gov/show/NCT01257815 |
Completed |
Novartis |
2013-04-30 |
| NCT01255293 |
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments |
https://ClinicalTrials.gov/show/NCT01255293 |
Completed |
Mid Atlantic Retina |
2012-10-31 |
| NCT01225653 |
Topical Application of Latanoprost in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01225653 |
Completed |
University of Aarhus |
2014-12-31 |
| NCT01223612 |
Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation |
https://ClinicalTrials.gov/show/NCT01223612 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2012-07-31 |
| NCT01202461 |
Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01202461 |
Completed |
Samsung Medical Center |
2010-08-31 |
| NCT01201161 |
Ranibizumab for Diabetic Traction Retinal Detachment |
https://ClinicalTrials.gov/show/NCT01201161 |
Completed |
University of Sao Paulo |
2010-01-31 |
| NCT01189461 |
Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01189461 |
Completed |
Pfizer |
2012-07-31 |
| NCT01179555 |
Confronting Unequal Eye Care in Pennsylvania |
https://ClinicalTrials.gov/show/NCT01179555 |
Completed |
Wills Eye |
2014-05-31 |
| NCT01115257 |
Severe Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01115257 |
Completed |
Universita degli Studi di Catania |
2006-10-31 |
| NCT01102946 |
Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01102946 |
Completed |
University of Sao Paulo |
2011-02-28 |
| NCT01075347 |
Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries |
https://ClinicalTrials.gov/show/NCT01075347 |
Completed |
National Taiwan University Hospital |
2008-03-31 |
| NCT01069341 |
Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01069341 |
Completed |
Bhagat, Neelakshi, M.D., M.P.H. |
2011-12-31 |
| NCT01041690 |
Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease |
https://ClinicalTrials.gov/show/NCT01041690 |
Completed |
Cairo University |
2008-06-30 |
| NCT01025934 |
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01025934 |
Completed |
University of Campania “Luigi Vanvitelli” |
NA |
| NCT01009021 |
Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01009021 |
Completed |
University of Sao Paulo |
2009-03-31 |
| NCT00996437 |
Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) |
https://ClinicalTrials.gov/show/NCT00996437 |
Completed |
Jaeb Center for Health Research |
2012-02-29 |
| NCT00970723 |
High Blood Pressure and Sleep Apnea in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00970723 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-01-31 |
| NCT00917553 |
Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00917553 |
Completed |
Milton S. Hershey Medical Center |
2012-07-31 |
| NCT00907114 |
Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00907114 |
Completed |
Hospital Juarez de Mexico |
2015-03-31 |
| NCT00904592 |
A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00904592 |
Completed |
Chengdu University of Traditional Chinese Medicine |
2010-10-31 |
| NCT00900887 |
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema |
https://ClinicalTrials.gov/show/NCT00900887 |
Completed |
Hospital Juarez de Mexico |
2015-03-31 |
| NCT00864838 |
Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab |
https://ClinicalTrials.gov/show/NCT00864838 |
Completed |
University of Sao Paulo |
2009-02-28 |
| NCT04448496 |
Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema |
https://ClinicalTrials.gov/show/NCT04448496 |
Recruiting |
Yeungnam University College of Medicine |
2021-12-31 |
| NCT03752840 |
Village-Integrated Eye Worker Trial II |
https://ClinicalTrials.gov/show/NCT03752840 |
Recruiting |
Francis I. Proctor Foundation |
2023-07-31 |
| NCT00814008 |
The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp |
https://ClinicalTrials.gov/show/NCT00814008 |
Completed |
Medical University of Vienna |
2000-04-30 |
| NCT01853072 |
Nepafenac Once Daily for Macular Edema - Study 1 |
https://ClinicalTrials.gov/show/NCT01853072 |
Completed |
Alcon Research |
2015-05-31 |
| NCT00806169 |
Combined Triple Therapy in Diabetic Retinopathy (DRP) |
https://ClinicalTrials.gov/show/NCT00806169 |
Completed |
Johann Wolfgang Goethe University Hospital |
2008-10-31 |
| NCT00804921 |
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab |
https://ClinicalTrials.gov/show/NCT00804921 |
Completed |
University of Sao Paulo |
NA |
| NCT00802269 |
Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. |
https://ClinicalTrials.gov/show/NCT00802269 |
Completed |
Asociación para Evitar la Ceguera en México |
2008-11-30 |
| NCT02579837 |
CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease |
https://ClinicalTrials.gov/show/NCT02579837 |
Active, not recruiting |
Western University, Canada |
2020-07-31 |
| NCT02486484 |
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection |
https://ClinicalTrials.gov/show/NCT02486484 |
Recruiting |
Rafic Hariri University Hospital |
2019-05-31 |
| NCT04009980 |
Long-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus. |
https://ClinicalTrials.gov/show/NCT04009980 |
Completed |
Fondazione G.B. Bietti, IRCCS |
2018-10-31 |
| NCT00782717 |
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT00782717 |
Completed |
Alcon Research |
2010-07-31 |
| NCT00776763 |
Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab |
https://ClinicalTrials.gov/show/NCT00776763 |
Completed |
Ophthalmological Association Edelweiss |
2009-10-31 |
| NCT00745498 |
Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy |
https://ClinicalTrials.gov/show/NCT00745498 |
Completed |
Seoul National University Bundang Hospital |
2010-10-31 |
| NCT00711490 |
Sirolimus to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00711490 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-01-31 |
| NCT00690768 |
Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) |
https://ClinicalTrials.gov/show/NCT00690768 |
Completed |
University of Sao Paulo |
2008-05-31 |
| NCT00682240 |
Morphological and Functional Retinal Changes Following Retinal Photocoagulation |
https://ClinicalTrials.gov/show/NCT00682240 |
Completed |
Medical University of Vienna |
2014-02-28 |
| NCT00665106 |
Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00665106 |
Completed |
Santen SAS |
2011-09-30 |
| NCT00656435 |
Bevacizumab and Long Acting Gas in Diabetic Vitrectomy |
https://ClinicalTrials.gov/show/NCT00656435 |
Completed |
National Taiwan University Hospital |
2007-08-31 |
| NCT00619034 |
Pharmacological Intervention in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00619034 |
Completed |
University of Aarhus |
2010-12-31 |
| NCT00606138 |
Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging |
https://ClinicalTrials.gov/show/NCT00606138 |
Completed |
Rush University Medical Center |
2010-10-31 |
| NCT00604383 |
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study |
https://ClinicalTrials.gov/show/NCT00604383 |
Completed |
Chromaderm, Inc. |
2005-06-30 |
| NCT00600262 |
Intravitreal Bevacizumab for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00600262 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT00600236 |
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population |
https://ClinicalTrials.gov/show/NCT00600236 |
Completed |
Asociación para Evitar la Ceguera en México |
2008-01-31 |
| NCT00596297 |
Preoperative Bevacizumab for Vitreous Hemorrhage |
https://ClinicalTrials.gov/show/NCT00596297 |
Completed |
University of Sao Paulo |
2008-09-30 |
| NCT00594152 |
Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) |
https://ClinicalTrials.gov/show/NCT00594152 |
Completed |
Joslin Diabetes Center |
NA |
| NCT00548197 |
Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment |
https://ClinicalTrials.gov/show/NCT00548197 |
Completed |
Iran University of Medical Sciences |
2008-02-29 |
| NCT00545870 |
Bevacizumab Versus Ranibizumab for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00545870 |
Completed |
Medical University of Vienna |
2013-03-31 |
| NCT00542178 |
Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) |
https://ClinicalTrials.gov/show/NCT00542178 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2009-12-31 |
| NCT00529594 |
Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT00529594 |
Completed |
University of Sao Paulo |
NA |
| NCT00511875 |
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00511875 |
Completed |
Milton S. Hershey Medical Center |
2012-05-31 |
| NCT00500097 |
Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training |
https://ClinicalTrials.gov/show/NCT00500097 |
Completed |
Ministry of Health, Thailand |
NA |
| NCT00496405 |
Unilateral Bevacizumab for Bilateral Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00496405 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT00446381 |
Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) |
https://ClinicalTrials.gov/show/NCT00446381 |
Completed |
Lawson Health Research Institute |
2008-09-30 |
| NCT00445003 |
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00445003 |
Completed |
Jaeb Center for Health Research |
2009-10-31 |
| NCT00444600 |
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00444600 |
Completed |
Jaeb Center for Health Research |
2009-12-31 |
| NCT00443521 |
Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00443521 |
Completed |
University of Sao Paulo |
NA |
| NCT00799695 |
Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population |
https://ClinicalTrials.gov/show/NCT00799695 |
Completed |
Henry Ford Health System |
2008-05-31 |
| NCT00423059 |
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00423059 |
Completed |
Yonsei University |
NA |
| NCT00414999 |
A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00414999 |
Completed |
TargeGen |
NA |
| NCT00411970 |
20- Versus 23- Gauge System for Pars Plana Vitrectomy |
https://ClinicalTrials.gov/show/NCT00411970 |
Completed |
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
NA |
| NCT00411333 |
Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00411333 |
Completed |
National Eye Institute (NEI) |
2009-07-31 |
| NCT00406991 |
Retinal Blood Flow and Microthrombi in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT00406991 |
Completed |
Massachusetts Eye and Ear Infirmary |
NA |
| NCT00401115 |
Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00401115 |
Completed |
Santen Inc. |
2008-06-30 |
| NCT00387582 |
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00387582 |
Completed |
Rocky Mountain Retina Consultants |
2009-02-28 |
| NCT00385333 |
Metabolic Mapping to Measure Retinal Metabolism |
https://ClinicalTrials.gov/show/NCT00385333 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-06-01 |
| NCT00355680 |
Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00355680 |
Completed |
Aurolab |
2006-07-31 |
| NCT00337298 |
The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT00337298 |
Completed |
University of Aarhus |
2009-02-28 |
| NCT00336323 |
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) |
https://ClinicalTrials.gov/show/NCT00336323 |
Completed |
Jaeb Center for Health Research |
2006-11-30 |
| NCT00295828 |
A Pilot Study for the Treatment of Iris Neovascularization With Macugen |
https://ClinicalTrials.gov/show/NCT00295828 |
Completed |
Hermann Eye Center |
2008-09-30 |
| NCT00266695 |
Treatment for Completers of the Study B7A-MC-MBCM |
https://ClinicalTrials.gov/show/NCT00266695 |
Completed |
Chromaderm, Inc. |
2008-08-31 |
| NCT00252733 |
Diabetic Retinopathy Candesartan Trials |
https://ClinicalTrials.gov/show/NCT00252733 |
Completed |
AstraZeneca |
2008-04-30 |
| NCT00252720 |
DIabetic Retinopathy Candesartan Trials. |
https://ClinicalTrials.gov/show/NCT00252720 |
Completed |
AstraZeneca |
2008-02-29 |
| NCT00252694 |
DIabetic Retinopathy Candesartan Trials |
https://ClinicalTrials.gov/show/NCT00252694 |
Completed |
AstraZeneca |
2008-02-29 |
| NCT00231023 |
Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00231023 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00198510 |
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage |
https://ClinicalTrials.gov/show/NCT00198510 |
Completed |
Bausch & Lomb Incorporated |
2001-09-30 |
| NCT00198497 |
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage |
https://ClinicalTrials.gov/show/NCT00198497 |
Completed |
Bausch & Lomb Incorporated |
2001-09-30 |
| NCT00198471 |
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment |
https://ClinicalTrials.gov/show/NCT00198471 |
Completed |
Bausch & Lomb Incorporated |
2006-11-30 |
| NCT00174824 |
Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients |
https://ClinicalTrials.gov/show/NCT00174824 |
Completed |
Sanofi |
2007-04-30 |
| NCT00155454 |
Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy |
https://ClinicalTrials.gov/show/NCT00155454 |
Completed |
National Taiwan University Hospital |
2012-12-31 |
| NCT00131144 |
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00131144 |
Completed |
Novartis |
2005-12-31 |
| NCT00130845 |
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00130845 |
Completed |
Novartis |
2005-12-31 |
| NCT00119535 |
Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes |
https://ClinicalTrials.gov/show/NCT00119535 |
Completed |
VA Office of Research and Development |
NA |
| NCT00105404 |
Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT00105404 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00101764 |
Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders |
https://ClinicalTrials.gov/show/NCT00101764 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00090519 |
Reduction in the Occurrence of Center-Involved Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00090519 |
Completed |
Chromaderm, Inc. |
2010-04-30 |
| NCT00069056 |
Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00069056 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00035906 |
Research Study in Patients With Persistent Macular Edema |
https://ClinicalTrials.gov/show/NCT00035906 |
Completed |
Allergan |
2004-08-31 |
| NCT00000160 |
Diabetic Retinopathy Study (DRS) |
https://ClinicalTrials.gov/show/NCT00000160 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000159 |
Sorbinil Retinopathy Trial (SRT) |
https://ClinicalTrials.gov/show/NCT00000159 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000154 |
Diabetic Retinopathy Vitrectomy Study (DRVS) |
https://ClinicalTrials.gov/show/NCT00000154 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000153 |
Krypton-Argon Regression of Neovascularization Study (KARNS) |
https://ClinicalTrials.gov/show/NCT00000153 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000151 |
Early Treatment Diabetic Retinopathy Study (ETDRS) |
https://ClinicalTrials.gov/show/NCT00000151 |
Completed |
National Eye Institute (NEI) |
NA |